Shell Asset Management Co. Sells 2,254 Shares of Waters Corporation $WAT

Shell Asset Management Co. reduced its holdings in shares of Waters Corporation (NYSE:WAT) by 43.0% during the third quarter, HoldingsChannel reports. The firm owned 2,993 shares of the medical instruments supplier’s stock after selling 2,254 shares during the period. Shell Asset Management Co.’s holdings in Waters were worth $897,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Deroy & Devereaux Private Investment Counsel Inc. raised its holdings in Waters by 41.9% in the 3rd quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 13,802 shares of the medical instruments supplier’s stock worth $4,138,000 after purchasing an additional 4,077 shares during the period. Veritas Asset Management LLP purchased a new position in Waters in the 3rd quarter worth approximately $175,320,000. Envestnet Asset Management Inc. boosted its position in shares of Waters by 5.0% during the second quarter. Envestnet Asset Management Inc. now owns 126,070 shares of the medical instruments supplier’s stock worth $44,004,000 after acquiring an additional 5,980 shares during the last quarter. Figure 8 Investment Strategies LLC boosted its holdings in shares of Waters by 46.4% during the 3rd quarter. Figure 8 Investment Strategies LLC now owns 7,793 shares of the medical instruments supplier’s stock valued at $2,336,000 after purchasing an additional 2,471 shares during the last quarter. Finally, Union Bancaire Privee UBP SA purchased a new position in shares of Waters in the 3rd quarter worth $1,624,000. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on WAT. Wall Street Zen cut shares of Waters from a “buy” rating to a “hold” rating in a research report on Sunday, February 8th. Evercore ISI assumed coverage on Waters in a research report on Tuesday, February 10th. They set a “hold” rating and a $360.00 price objective on the stock. Guggenheim reiterated a “buy” rating and issued a $440.00 target price on shares of Waters in a report on Tuesday, February 10th. TD Cowen reissued a “hold” rating on shares of Waters in a research report on Wednesday, November 5th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Waters in a research report on Wednesday, January 21st. Two analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $397.68.

Waters Trading Up 1.3%

WAT opened at $323.91 on Tuesday. The company has a quick ratio of 1.01, a current ratio of 1.41 and a debt-to-equity ratio of 0.41. The stock’s fifty day moving average is $379.34 and its two-hundred day moving average is $348.42. The company has a market capitalization of $19.29 billion, a P/E ratio of 30.07, a PEG ratio of 2.23 and a beta of 1.18. Waters Corporation has a 52 week low of $275.05 and a 52 week high of $414.15.

Waters (NYSE:WAT) last posted its quarterly earnings results on Monday, February 9th. The medical instruments supplier reported $4.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.50 by $0.03. The business had revenue of $932.36 million for the quarter, compared to the consensus estimate of $928.17 million. Waters had a return on equity of 34.79% and a net margin of 20.30%.The business’s revenue was up 6.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $4.10 EPS. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. Analysts forecast that Waters Corporation will post 12.86 earnings per share for the current year.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.